Side of LogoAETC National Resource Center HomeSide of LogoTop of Banner
Search Web site
spacespacespace
space

Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors

Source: U.S. Centers for Disease Control and Prevention
Date: 01/23/2004

Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV-Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors

Description:

MMWR. 53(02);37

Browse similar resources:

Topic Areas:

Tuberculosis Coinfection

Resource Type:

Coinfection Guidelines (Hep, TB, STIs)

Group:

Guidelines

space
space
Materials Usage Guidelines

We ask that those wishing to use the materials found on the AETC NRC website honor the following guidelines:

  • Slide sets and other materials that appear on the AETC NRC website are intended for public use, unless otherwise noted.
  • You may use or present a slide set or other material in its entirety if you credit the author and source of the material.
  • Similarly, you may incorporate selected slides or resources from the AETC NRC website into another public presentation if you credit the author and/or source of the materials.
  • If you use materials from the AETC NRC website in preparing other presentations or materials, please Include an appropriate reference citation.
  • Do not publish or post materials found on the AETC NRC site without permission from their creators or copyright holders.
  • For examples of appropriate citation, see our Using and Adapting Slides frequently asked questions.
close

Copyright 2010, the AIDS Education & Training Centers National Resource Center, unless otherwise noted. All rights reserved. Email webmaster@aidsetc.org with questions, comments, or problems. See disclaimer for usage guidelines.

space